Ying-Yin Chen
Overview
Explore the profile of Ying-Yin Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Chang C, Hou H, Chien N, Lu K, Chen Y, et al.
ERJ Open Res
. 2025 Mar;
11(2).
PMID: 40071267
Background: The radiology, obstruction, symptoms and exposure (ROSE) criteria provide a standardised approach for identifying the "COPD-bronchiectasis (BE) association." However, the clinical implications and outcomes of the COPD-BE association in...
2.
Chuang H, Chen Y, Chung Y, Huang E, Huang C, Lung J, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273683
Macrophages, pivotal components of the immune system, orchestrate host defense mechanisms in humans and mammals. Their polarization into classically activated macrophages (CAMs or M1) and alternatively activated macrophages (AAMs or...
3.
Chen Y, Hou H, Chien N, Lu K, Chen Y, Hung Z, et al.
Lung
. 2024 Jun;
202(5):695-709.
PMID: 38884647
Purpose: Bronchiectasis is predominantly marked by neutrophilic inflammation. The relevance of type 2 biomarkers in disease severity and exacerbation risk is poorly understood. This study explores the clinical significance of...
4.
Chang H, Chen S, Lin J, Chen Y, Chen Y, Liu Y, et al.
J Agric Food Chem
. 2024 Apr;
72(18):10406-10419.
PMID: 38659208
The impact of leptin resistance on intestinal mucosal barrier integrity, appetite regulation, and hepatic lipid metabolism through the microbiota-gut-brain-liver axis has yet to be determined. Water extract of L. fruit...
5.
Chang C, Chang S, Wei Y, Tseng Y, Chou C, Chen Y, et al.
Am J Cancer Res
. 2024 Apr;
14(3):1243-1257.
PMID: 38590421
The immune system plays a key role in detecting and fighting cancerous tumors. T cells are a crucial component in both natural and therapeutic cancer immunoediting responses, but it is...
6.
Lee I, Wang H, Chen Y, Chen C, Liao H
Am J Cancer Res
. 2024 Apr;
14(3):1227-1242.
PMID: 38590414
While T-cell-mediated immune responses in solid tumors have been well-established and have driven major therapeutic advances, our understanding of B-cell biology in cancer is comparatively less developed. A total of...
7.
Dong J, Wang R, Yuan N, Guo J, Yu X, Peng A, et al.
Front Cell Dev Biol
. 2023 May;
11:1160544.
PMID: 37143897
Hepatocellular carcinoma (HCC) accounts for approximately 90% of all primary liver cancers and is one of the main malignant tumor types globally. It is essential to develop rapid, ultrasensitive, and...
8.
Chen Y, Chen S, Lin J, Yen G
Mol Nutr Food Res
. 2023 Feb;
67(7):e2200791.
PMID: 36738163
Scope: Methylglyoxal (MG)-derived advanced glycation end products (AGEs) directly bind to the receptor for advanced glycation end products (RAGE), subsequently exacerbating obesity and obesity-induced cognitive decline. Indian gooseberry (Phyllanthus emblica...
9.
Chen Y, Chen S, Li T, Lin T, Chen C, Yen G
Oncol Lett
. 2022 Mar;
23(4):128.
PMID: 35251348
Gemcitabine (GEM) is a typical chemotherapeutic drug used to treat pancreatic cancer, but GEM resistance develops within weeks after chemotherapy. Hence, the development of a new strategy to overcome drug...
10.
Chen S, Hsu Y, Wang S, Chen Y, Hong C, Yen G
Phytother Res
. 2022 Feb;
36(4):1664-1677.
PMID: 35224793
Gemcitabine (GEM) drug resistance remains a difficult challenge in pancreatic ductal adenocarcinoma (PDAC) treatment. Therefore, identifying a safe and effective treatment strategy for PDAC is urgent. Lucidone is a natural...